Establishment Labs paves the way for a third facility, preparing to expand its capabilities in manufacturing, R&D and medical education
SANTA BARBARA, Calif .– (COMMERCIAL THREAD) – Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the aesthetic and breast reconstruction market, today hosted the ceremony inauguration of its new Sulayöm innovation campus in Costa Rica. When complete, the new facility will total approximately 145,000 square feet (13,500 square meters) and will support the company’s continued global growth with additional capabilities and capabilities in manufacturing, R&D, digital media , training and medical education.
“The inauguration of our Sulayöm innovation campus is a crucial next step in our growth, as Motiva Implants continues to be recognized as a new standard in breast aesthetics,” said Juan José Chacón-Quirós, CEO and Founder of Establishment Labs. “The name Sulayöm comes from Bribri, an indigenous language of Costa Rica, and translates to“ The place in the mountains at the center of the world ”. This new state-of-the-art facility will give us the manufacturing capacity to support our expected global growth over the next several years, from entering the United States and China to our market expansion initiatives in aesthetics. minimally invasive breast and breast reconstruction. We are also expanding our research labs for new development programs and improving our outreach, training and medical education capabilities in digital media. The campus underscores our commitment to a sustainable future and will continue our traditions of being carbon neutral and using sustainable materials and methods. After only a decade of commercial sales with Motiva, we are now eager to expand our capacity so that we can supply more than half of the current global market. ”
The new campus will be completed in two phases, the first phase is expected to cost around $ 35 million, the majority of which intends to finance with a local credit partner. Construction of the new building will begin after the finalization and execution of certain contractual agreements. The new facilities will create up to 1,000 new jobs over the next few years and will be located in the Coyol Free Zone in Costa Rica.
About establishment laboratories
Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health, initially in the aesthetic and breast reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio silicone gel-filled breast implants, such as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva® implants are produced at our two manufacturing sites in accordance with ISO13485: 2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in over 80 countries through exclusive distributors or the force direct sales of the company. In March 2018, Establishment Labs received Investigational Device Exemption (IDE) approval from the FDA and launched the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, the Establishment Labs’ product and technology portfolio includes the Divina® 3D simulation system and other products and services. Please visit our website for more information at www.establishmentlabs.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). You can find many of these statements (but not all) by searching for words such as “approximate”, “believes”, “expects”, “anticipates”, “estimates”, “intends”, “Plan”, ”“ would ”,“ will ”,“ may ”or other similar expressions in this press release. Factors, among others, that could cause actual results and events to differ materially from those described in forward-looking statements include risks and uncertainties relating to: our expected growth and product differentiation, our expansion plans future and capital allocation, construction and infrastructure development projects to be undertaken, our ability to enter into agreements to extend our credit agreements and / or obtain other sources of credit or capital, our ability to meet the financial commitments contained in our credit facilities, the legal agreements to be executed, the market acceptance of our products, the effects of manufacturing or assembly realignments, the availability of raw materials and specialized labor or the increase in their costs, our ability to identify and develop relationships with a sufficient number of qualified suppliers to avoid significant disruption to our supply chains, our ability to attract and retain key personnel, respect for environmental national laws, health and safety and / or building codes and standards, our ability to evolve our operations and realize the expected revenues and cost savings, and our ability to avoid damage to our facilities or other force majeure events that could disrupt our operations and expansion plans. Any statement that refers to projections of our future financial or operational performance, anticipated trends in our business, our objectives, strategies, priorities and plans, and other characterizations of future events or circumstances, including statements expressing general optimism about future operating results, related to the performance of the company are forward-looking statements. We claim the safe harbor protection contained in the Private Securities Litigation Reform Act of 1995. We caution investors that all forward-looking statements made in this report, or that we may make orally or in writing from time to time, are expressions of our beliefs and expectations based on information currently available at the time these statements are made. Such statements are based on assumptions, and actual results will be affected by known and unknown risks, trends, uncertainties and factors which are beyond our control. Although we believe our assumptions are reasonable, we cannot guarantee future performance, and some will inevitably prove to be inaccurate. Therefore, our actual future results and the timing of events may differ from our expectations, and these differences may be material. Factors that could cause or contribute to these differences include, among others, the risks and uncertainties discussed in the company’s annual report on Form 10-K filed on March 15, 2021, the quarterly reports on Form 10-Q and d ‘other documents filed by the company with the Securities and Exchange Commission. The risks included in these documents are not exhaustive and additional factors could adversely affect our business and financial performance. We operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for us to predict all of these risk factors, nor to assess the impact of all of these risk factors on our business or the extent to which any factor, or a combination of factors, may cause actual results to differ materially from those contained in forward-looking statements. We assume no obligation to update any forward-looking statements. Therefore, investors should exercise caution in relying on past forward-looking statements, which are based on results and trends known at the time they are made, to anticipate future results or trends.